Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for primary plasma cell leukemia in Japan finds no significant OS difference between the groups (median 3.2 years with auto-HCT and 1.4 years with allo).”
Title: Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Primary Plasma Cell Leukemia in Japan
Authors: Masaya Maegaki, Tsutomu Takahashi, Kazuhito Suzuki, Daisuke Minakata, Toshiki Terao, Atsushi Satake, Hangaishi Akira, Tatsuo Oyake, Yoshinobu Kanda, Nobuyuki Aotsuka, Nobuhiro Tsukada, Takayuki Tabayashi, Hikaru Kobayashi, Yuichiro Nawa, Tatsuo Ichinohe, Marie Ohbiki, Yoshiko Atsuta, and Koji Kawamura
You can read the Full Article in Transplantation and Cellular Therapy.
You can find more posts featuring Robert Orlowski on OncoDaily.
